You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Replication Competent Retrovirus (RCR)

Showing 1 - 25 of 863
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid and Hematological Malignancies Trial in United States (Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, KITE-585)

Enrolling by invitation
  • Solid and Hematological Malignancies
  • Axicabtagene Ciloleucel
  • Brexucabtagene Autoleucel (KTE-X19)
  • Duarte, California
  • +7 more
Jun 29, 2022

Acute Myeloid Leukemia, Multiple Myeloma Trial in Ostrava, Milan, Roma (MLM-CAR44.1 T-cells at day 0 Single intravenous

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Multiple Myeloma
  • MLM-CAR44.1 T-cells at day 0 Single intravenous infusion
  • Ostrava, Czech Republic, Czechia
  • +2 more
Dec 20, 2021

Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical

Not yet recruiting
  • Epidermolysis Bullosa
  • +2 more
  • EB-101 Surgical application of RDEB wounds
  • Redwood City, California
  • +1 more
Feb 13, 2023

Long-Term Follow-Up of Recipient of Gene Transfer Research

Recruiting
  • Retroviridae Infections
  • Cancer
  • Blood Tests
  • Questionnaires
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 22, 2022

Allogeneic Gamma Delta (?d) CAR T Cells

Enrolling by invitation
  • Lymphoma, Follicular
  • +5 more
  • ADI-001
  • Stanford, California
  • +4 more
Jun 7, 2022

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Solid Tumor Trial in Kashiwa, Chuo Ku (NIB101)

Recruiting
  • Solid Tumor
  • NIB101
  • Kashiwa, Chiba, Japan
  • +1 more
Feb 7, 2022

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL Trial in

Enrolling by invitation
  • Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
  • +4 more
  • AUTO CAR T cell therapy
  • London, United Kingdom
  • +3 more
Feb 2, 2022

Solid Tumor Trial in United States (KITE-718, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Solid Tumor
  • Gilbert, Arizona
  • +11 more
Apr 5, 2022

Relapsed/Refractory Waldenstrom Macroglobulinemia, Relapsed/Refractory Richter Transformation, Relapsed/Refractory Burkitt

Not yet recruiting
  • Relapsed/Refractory Waldenstrom Macroglobulinemia
  • +3 more
  • Brexucabtagene Autoleucel
  • +2 more
  • (no location specified)
Sep 8, 2022

HIV Trial in Liège (Treatment simplification (dolutegravir lamivudine))

Active, not recruiting
  • HIV Infections
  • Treatment simplification (dolutegravir lamivudine)
  • Liège, Belgium
    Liège university hospital
Apr 27, 2022

Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)

Enrolling by invitation
  • Immunologic Deficiency Syndromes
  • Strimvelis
  • Milano, Lombardia, Italy
    Orchard Investigational Site
Jun 23, 2021

HIV-1-infection Trial in Liège (Dolutegravir 50 MG)

Recruiting
  • HIV-1-infection
  • Dolutegravir 50 MG
  • Liège, Belgium
    Liège university hospital
Apr 27, 2022

Solid Tumors Trial in Kashiwa, Nishinomiya, Chuo-ku (TAK-103)

Recruiting
  • Solid Tumors
  • TAK-103
  • Kashiwa, Chiba, Japan
  • +2 more
Mar 10, 2022

Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Trial in United States (TAK-007, Chemotherapy Agents)

Recruiting
  • Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
  • TAK-007
  • Chemotherapy Agents
  • Birmingham, Alabama
  • +18 more
Aug 17, 2022

Survival of Genetically Modified White Blood Cells in

Active, not recruiting
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 3, 2023

    Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

    Recruiting
    • Lymphoma
    • +7 more
    • ATLCAR.CD30 cells
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Dec 2, 2022

    HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

    Terminated
    Has Results
    • HIV Infection
    • Recombinant Interleukin-2
    • Cleveland, Ohio
      AIDS Clinical Trials Unit
    Sep 1, 2022

    Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Trial in Worldwide

    Recruiting
    • Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
    • Previously treated CAR-T patients
    • Phoenix, Arizona
    • +71 more
    Nov 14, 2022

    Netherlands Cohort Study on Acute HIV Infection

    Recruiting
    • Acute HIV Infection
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam UMC, location AMC
      Feb 6, 2023

      Rotator Cuff Tears Trial in Portland, Meyrin (Arthroscopy, Reverse Shoulder Arthroplasty)

      Recruiting
      • Rotator Cuff Tears
      • Arthroscopy
      • Reverse Shoulder Arthroplasty
      • Portland, Oregon
      • +1 more
      Mar 29, 2023

      Patients Previously Treated With a Juno CAR T-Cell Product

      Terminated
      • Non Hodgkin Lymphoma
      • +5 more
      • JCAR017
      • JCARH125
      • Duarte, California
      • +1 more
      Apr 30, 2020

      Pancreatic Adenocarcinoma, Ovarian Cancer, Biliary Carcinoma Trial in Stockholm, Uppsala (LOAd703)

      Recruiting
      • Pancreatic Adenocarcinoma
      • +3 more
      • Stockholm, Sweden
      • +1 more
      Apr 4, 2022

      Multiple Myeloma, Immune System Diseases Trial in Chapel Hill (CAR138 T Cells)

      Recruiting
      • Multiple Myeloma
      • Immune System Diseases
      • CAR138 T Cells
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center at University of North Ca
      Jan 10, 2023

      Congenital Heart Disease in Children Trial in Kansas City (Remote Cardiac Rehabilitation, Active Control)

      Recruiting
      • Congenital Heart Disease in Children
      • Remote Cardiac Rehabilitation
      • Active Control
      • Kansas City, Missouri
        Children's Mercy Kansas City
      Aug 31, 2023